TREM2 and Alzheimer disease: Recent genome wide association studies implicate several genes related to the immune system (e.g., CD33, HLA-DRB5-HLA-DRB1) and proteins highly expressed in microglia (e.g., triggering receptor expressed on myeloid cells 2 [TREM2]) increase risk for sporadic, late-onset AD [129].